Abstract
A concise and efficient route for the synthesis of indole derivatives having propellane structure at position 3 by simple regioselective one-pot reaction of ninhydrin, malononitrile, tryptamine, and β-dicarbonyl compounds was developed. This protocol provides an alternative method for application in combinatorial and parallel synthesis in drug discovery. The value of this method lies in its simplicity, regioselectivity, and good yields. The structures of new synthesized compounds were corroborated spectroscopically (IR, 1H- and 13C-NMR, and EI-MS). A plausible mechanism for this type of reaction is proposed (Scheme 2).
Keywords: Indole, propellane, tryptamin, ninhydrin, one-pot reaction.
Graphical Abstract
Letters in Organic Chemistry
Title:Tandem One-Pot Synthesis of Indoles Having a Structural Moiety of Propellane
Volume: 12 Issue: 3
Author(s): Abdolali Alizadeh, Fahimeh Bayat and Vahideh Sadeghi
Affiliation:
Keywords: Indole, propellane, tryptamin, ninhydrin, one-pot reaction.
Abstract: A concise and efficient route for the synthesis of indole derivatives having propellane structure at position 3 by simple regioselective one-pot reaction of ninhydrin, malononitrile, tryptamine, and β-dicarbonyl compounds was developed. This protocol provides an alternative method for application in combinatorial and parallel synthesis in drug discovery. The value of this method lies in its simplicity, regioselectivity, and good yields. The structures of new synthesized compounds were corroborated spectroscopically (IR, 1H- and 13C-NMR, and EI-MS). A plausible mechanism for this type of reaction is proposed (Scheme 2).
Export Options
About this article
Cite this article as:
Alizadeh Abdolali, Bayat Fahimeh and Sadeghi Vahideh, Tandem One-Pot Synthesis of Indoles Having a Structural Moiety of Propellane, Letters in Organic Chemistry 2015; 12 (3) . https://dx.doi.org/10.2174/1570178612666150108003359
DOI https://dx.doi.org/10.2174/1570178612666150108003359 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enzymatic Properties and Physiological Roles of Cytosolic 5’-Nucleotidase II.
Current Medicinal Chemistry CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery
Current Drug Targets A Novel Information Theoretic Approach to Gene Selection for Cancer Classification Using Microarray Data
Current Bioinformatics Cucurbitacins as Inducers of Cell Death and a Rich Source of Potential Anticancer Compounds
Current Pharmaceutical Design CREG: A Possible Candidate for Both Prevention and Treatment of Proliferative Vascular Disease
Current Molecular Medicine Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth,Angiogenesis and Metastasis
Current Pharmaceutical Design Aim for the Readers! Bromodomains As New Targets Against Chagas’ Disease
Current Medicinal Chemistry Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using `In silico Pharmacology`
Current Protein & Peptide Science Self-Assembled Peptide Nanoarchitectures: Applications and Future Aspects
Current Topics in Medicinal Chemistry Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Boron Nitride Nanotubes: Production, Properties, Biological Interactions and Potential Applications as Therapeutic Agents in Brain Diseases
Current Nanoscience Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Platelet-derived Growth Factor Receptor (PDGFR) Kinase Inhibitors
Current Drug Metabolism Meet Our Editorial Board Member
Recent Patents on Biotechnology Identification of Disease States and Response to Therapy in Humans by Utilizing the Biomarker EGFR for Targeted Molecular Imaging
Current Protein & Peptide Science The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Group-sparse Modeling Drug-kinase Networks for Predicting Combinatorial Drug Sensitivity in Cancer Cells
Current Bioinformatics Combination of Anti-EGFR Drugs with Anti-Angiogenic or Other Signal Transduction Inhibitors as a Rational Approach to Cancer Therapy
Current Cancer Therapy Reviews Osteoporotic Fracture Healing: Potential Use of Medicinal Plants from the Tropics
Current Drug Targets